The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease
about
Simulated presence therapy for dementiaThe BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical reviewPharmacological management of behavioral symptoms associated with dementiaAssessment and management of behavioral and psychological symptoms of dementiaScreening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production.Simulated presence therapy for dementia.Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.Genetics of Psychosis in Alzheimer Disease.Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study.Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.Pharmacotherapy of neuropsychiatric symptoms of dementiaAntipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study.Concomitant use of two or more antipsychotic drugs is common in Sweden.Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Simulated presence therapy for dementia: a systematic review protocolPrinciples and management of neuropsychiatric symptoms in Alzheimer's dementiaClinicians' prescription preferences for treating patients with Alzheimer's disease in Shanghai.Antipsychotic Use and Risk of Nursing Home Admission Among Dual-Eligible Medicare Beneficiaries: A Propensity-Matched Study.Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease.Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analysesTreatment of dementia with lewy bodiesImpact of a Videoconference Educational Intervention on Physical Restraint and Antipsychotic Use in Nursing Homes: Results From the ECHO-AGE Pilot StudyIncident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's DiseaseProgresses in treating agitation: a major clinical challenge in Alzheimer's disease.Antipsychotic prescription and mortality in hospitalized older persons.Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.Predictors of long-term care placement in persons with dementia: a systematic review and meta-analysis.Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.Nanobiomaterials' applications in neurodegenerative diseases.Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration.Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients.Comprehensive treatment of dementia with Lewy bodies.Dementia, neuropsychiatric symptoms, and the use of psychotropic drugs among older people who receive domiciliary care: a cross-sectional study.The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission and Death among Dementia Patients.Conflicts of interest in psychiatry: strategies to cultivate literacy in daily practice.Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.Why are more highly educated people with dementia less likely to be prescribed antipsychotics?
P2860
Q24187490-C3D03179-F7C5-4F5A-AE0A-A4BA863A2CC6Q27022753-9D668356-C052-4D57-ACE1-AF98574E7E20Q28081955-72FEA40D-9227-4FAC-AA02-60329AF36487Q28088782-7BBAECA2-5CCB-45DA-8E08-D87E6040A2E6Q30361852-3CDC6667-6CC0-47C8-A5FE-4DC7BD790D71Q30401151-A7109F71-93F2-4A4E-B4B7-17D5E7795414Q30423717-A4CA09F1-75D3-43BA-BBCA-2BB861EA9496Q33604532-0C390C37-5BC6-421F-834F-240776A88AB2Q33666458-6B7CA540-DC8B-4F43-B3AB-9C4F5AD79D7CQ33736204-6E1756B8-96B2-4333-91F6-844F9A9C769AQ34070862-2E10703F-3F0C-4EFE-811A-8367C17BC249Q34139476-3B35BDBF-E96E-42D3-85D1-2DB85AECDDBCQ35229781-0FD0628E-E194-4847-AC82-41D61E1DBF69Q35630897-5BE1CBCF-C85F-45E5-8C65-504BAC61314CQ35802750-E1EFD7EE-D043-42E4-8736-69C6BE4935A1Q35948865-1504DF1B-F3C4-42FB-99AE-271D86CDD8E6Q35975139-7F432D92-492A-45C6-843F-20EEA91FE2A9Q36015027-DD936C54-3113-4684-91C4-192C992C1C46Q36063264-1C9356B9-4423-4A83-9405-5762145689CDQ36830837-7A03A3B5-7D9E-4AF2-BDB3-EBC591529DD0Q36942854-04E96566-337C-40E8-9BF6-72FF70345810Q37076865-A10618D8-DBCE-4093-A8C0-57911890FC9EQ37196381-D372A3C7-C1F5-41C4-A155-C4A0F0AD6868Q37552865-CE0ADD34-C622-4AAF-B481-5E9984E6A2ACQ37673987-EA6CA5F9-3F79-4606-A152-F227A6587EADQ37729390-C9A5366E-3C3B-45BE-9D1D-D921CD22AC81Q38590192-5D377C46-45E7-4F6F-BBCC-5C989C49D7C4Q38738984-B3D7E2C1-39B5-4CF4-B2D2-1EF4AB14EA6BQ38764962-EB0DA871-7541-4614-83C4-379811F352A4Q38798301-92EE611C-C615-4271-9512-EE2BC573B9BBQ38998475-06004AC2-8073-4E25-BF5B-5E05F8EB99D3Q39126802-64759E58-CBFA-4240-9DC6-415ED77B2F19Q40106280-AA626F3A-3FBD-4F2A-B4C8-F0159A17E5A0Q41192516-6279F7BE-5C84-42C4-904B-46AC41E892DCQ41317541-2BC447E7-DAFB-47C8-989C-763BE6F06DC0Q45905937-1122405F-1232-467C-B59E-DDC0D86F648EQ47330521-16824B5C-A695-4024-A7B3-1F2080E7EC88Q48077253-EF6182C7-CB39-469B-8A37-F32C83C26364Q48319473-26A57B03-3421-438C-9252-A09C249847AFQ50605024-657A8A22-8AFD-4C66-9638-2F5E7201F364
P2860
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The long-term effects of conve ...... h probable Alzheimer's disease
@ast
The long-term effects of conve ...... h probable Alzheimer's disease
@en
type
label
The long-term effects of conve ...... h probable Alzheimer's disease
@ast
The long-term effects of conve ...... h probable Alzheimer's disease
@en
prefLabel
The long-term effects of conve ...... h probable Alzheimer's disease
@ast
The long-term effects of conve ...... h probable Alzheimer's disease
@en
P2093
P2860
P50
P1476
The long-term effects of conve ...... h probable Alzheimer's disease
@en
P2093
Beth Snitz
Eric McDade
Judith Saxton
M Ilyas Kamboh
Oscar L Lopez
Robert A Sweet
Steven T DeKosky
Yue-Fang Chang
P2860
P304
P356
10.1176/APPI.AJP.2013.12081046
P407
P577
2013-09-01T00:00:00Z